8/6/2013 7:10:24 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
SOUTH SAN FRANCISCO, Calif., Aug. 6, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today reported financial results for the second quarter and six months ended June 30, 2013.
For the second quarter of 2013, Rigel reported a net loss of $22.8 million, or $0.26 per share, compared to a net loss of $24.7 million, or $0.35 per share, in the same period of 2012
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by